HealthCentral
Why People With Obesity Are Missing in Clinical Trials
Dr. Pichamol Jirapinyo highlighted the exclusion of obese individuals from clinical trials and its implications.
Explore the latest news and coverage about Bariendo
Dr. Pichamol Jirapinyo highlighted the exclusion of obese individuals from clinical trials and its implications.
Dr. Jirapinyo advises only taking GLP-1 medications under a doctor's supervision and cautions against non-FDA-approved versions.
Dr. Thompson advocates treating obesity as a disease using GLP-1 medications, ESG, and lifestyle changes.
Dr. Thompson explains weight loss plateaus occur when weight remains unchanged for a month despite consistent diet and exercise.
Dr. Thompson highlights that tirzepatide lowers normal blood pressure with weight loss, not hypertension.